10 completed, 1 recruiting, 1 terminated, 1 unknown. 6 Not applicable, 3 Phase 2, 2 Phase 4, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 3, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 2 | 3 | Completed 3 |
| Phase 4 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Erythematotelangiectatic Rosacea: new trials by email Literature Review of Erythematotelangiectatic Rosacea trials Research Report on Erythematotelangiectatic Rosacea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea Doxycycline, Hydroxychloroquine, Tofacitinib - Erythematotelangiectatic Rosacea | Not applicable | Recruiting | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 186 | 2026-02-01 | 2026-03-24 |
| Intradermal BoNT-A Treatment in Erythematotelangiectatic Rosacea Botulinum toxin A, Placebo - Erythematotelangiectatic Rosacea | Phase 4 | Completed | Istanbul Training and Research Hospital | 30 | 2022-11-01 | 2024-03-29 |
| Pulsed Dye Laser and Intense Pulsed Light Configured With Different Wavelength Bands in Improving Erythematotelangiectatic Rosacea PDL(595nm), IPL(DPL), IPL(M22 590) - Erythematotelangiectatic Rosacea | Not applicable | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 60 | 2022-03-27 | 2022-05-04 |
| Evaluation of the New Laser PHOTOLASE PLV-585nm for the Treatment of Rosacea Excel V 532nm (KTP) green Laser, PHOTOLASE PLV 585 nm yellow laser - Erythematotelangiectatic Rosacea | Not applicable | Terminated | University Hospital, Lille | 1 | 2020-09-08 | 2022-03-15 |
| Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea The Vbeam® Prima System, Oxymetazoline HCL 1% Cream - Erythematotelangiectatic Rosacea | Phase 4 | Completed | Candela Corporation | 34 | 2019-01-15 | 2022-03-31 |
| A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea Reference: Metronidazole Gel 1%, Test: Metronidazole Gel 1%, Placebo Gel - Papulopustular Rosacea, Erythematotelangiectatic Rosacea | Phase 3 | Completed | bioRASI, LLC | 963 | 2015-02-01 | 2020-09-03 |
| Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea 532nm KTP Laser vs 595nm Pulse Dye Laser - Erythematotelangiectatic Rosacea, Papulopustular Rosacea | Not applicable | Completed | Cutera Inc. | 22 | 2014-09-01 | 2023-02-21 |
| Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea Ulthera System Treatment - Erythematotelangiectatic Rosacea, Rosacea | Not applicable | Completed | Ulthera, Inc | 88 | 2014-05-01 | 2018-01-31 |
| Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients PAC-14028 cream 1%, Vehicle, Rozex gel 0.75% - Erythematotelangiectatic Rosacea, Papulopustular Rosacea | Phase 2 | Completed | Amorepacific Corporation | 80 | 2013-02-01 | 2014-02-03 |
| Feasibility Study: Ulthera System for the Treatment of Rosacea Ulthera System providing one treatment per cheek, Ulthera System providing two treatments per cheek - Erythematotelangiectatic Rosacea | Not applicable | Completed | Ulthera, Inc | 12 | 2012-11-01 | 2017-11-24 |
| Open Label Pilot Study of Apremilast in Treatment of Rosacea Apremilast - Erythematotelangiectatic Rosacea, Papulopustular Rosacea | Phase 2 | Completed | Julian M. Mackay-Wiggan | 10 | 2010-06-01 | 2016-12-13 |
| Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea CD07805/47, CD07805/47 placebo - Erythematotelangiectatic Rosacea | Phase 2 | Completed | Galderma R&D | 122 | 2009-09-01 | 2021-02-18 |
| Combination Therapy for the Treatment of Rosacea calcium dobesilate, pulsed dye laser - Erythematotelangiectatic Rosacea | Phase 1 | Completed | Ellen Marmur | 6 | 2009-07-01 | 2019-06-17 |
Rosacea (13) · Telangiectasis (3) · Erythema (1) · Skin Diseases (1)
Skin and Connective Tissue Diseases (13) · Skin Diseases (12) · Cardiovascular Diseases (3) · Vascular Diseases (3) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Skin Manifestations (1)
Botulinum Toxins, Type A (1) · Calcium Dobesilate (1) · Doxycycline (1) · Hydroxychloroquine (1) · Lasers, Dye (1) · Metronidazole (1) · N-(1-(3,5-difluoro-4-methanesulfonylaminophenyl)ethyl)-3-(2-propyl-6-trifluoromethylpyridine-3-yl)acrylamide (1) · Oxymetazoline (1) · Sodium Chloride (1) · apremilast (1) · tofacitinib (1)
Ulthera, Inc (2) · Amorepacific Corporation (1) · Candela Corporation (1) · Cutera Inc. (1) · Ellen Marmur (1) · Galderma R&D (1) · Istanbul Training and Research Hospital (1) · Julian M. Mackay-Wiggan (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · The Fourth Affiliated Hospital of Zhejiang University School of Medicine (1) · University Hospital, Lille (1) · bioRASI, LLC (1)
United States (7) · Canada (2) · China (2) · France (1) · South Korea (1) · Turkey (Türkiye) (1)
BeomJoon Kim, Professor (1) · Ellen Marmur, MD (1) · Julian Mackay-Wiggan, MD, MS (1) · Konika P Schallen, MD (1) · Mark Lupin, M.D. (1) · Mark Lupin, MD (1) · Michael Graeber, MD (1) · Stephen Ronan, MD (1) · Suiqing S Cai, doctor (1)